onyx pharmaceuticals inc
(ONXX:NASDAQ GS)

Executive Profile*

Background*

Ms. Suzanne M. Shema, JD has been General counsel of Onyx Pharmaceuticals, Inc. since August 2009 and has been its Corporate Secretary and Executive Vice President since January 2012 and also served as its Senior Vice President from August 2009 to January 2012. Prior to joining Onyx, Ms. Shema served as General counsel and Senior Vice President of Zymogenetics Inc. since February 2006 and its Secretary since June 2004. Ms. Shema served as Senior Vice President, Intellectual ... Property and Legal Affairs of Zymogenetics from April 2003 to February 2006, which she joined in 2001. Previously, Ms. Shema served as Zymogenetics Inc.'s Vice President, Intellectual Property and Legal Affairs from December 2001 to April 2003 and Senior Director of Intellectual Property from May 2001 to December 2001. From February 2000 to May 2001, Ms. Shema served as General Counsel at aQuantive, Inc., an internet advertising company. From July 1998 to February 2000, Ms. Shema served as corporate counsel at ZymoGenetics. From 1991 to March 1998, she served as Associate General Counsel at Research Corporation Technologies, Inc., a technology management company. From 1989 to 1991, Ms. Shema served as Associate General Counsel at NeoRx Corporation, a biotechnology company. From 1985 to 1988, she served as an associate at the law firm of Seed and Berry. Ms. Shema holds a B.S. in Chemistry from the University of Texas, an M.S. in Chemistry from the University of Washington and a J.D. from the University of Washington School of Law.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
ONXX:US	$92.91 USD	-1.43

COMPETITOR COMPENSATION